Clinical study of azithromycin andcefazolin in treatment of respiratory tract infections
- VernacularTitle:阿奇霉素与头孢唑啉治疗呼吸道感染的临床对照研究
- Author:
Xiu LI
;
Ying ZHANG
;
Su-Ping ZHANG
;
Lei MENG
;
- Publication Type:Journal Article
- Keywords:
azithromycin;
cefazolin;
respiratory tract infection
- From:
Chinese Journal of Clinical Pharmacology and Therapeutics
2000;0(02):-
- CountryChina
- Language:Chinese
-
Abstract:
Aim To evaluate the effect and safety of azithromycin injection produced in China and cefazolin in the treatment of respiratory tract infections.Methods 50 patients with respiratory tract infections were divided randomly into two groups. Patients in the test group recieved azithromycin in the dosage of 250 mg?d-1,qd for 5 d iv with double dosages at the first time and patients in the control group recieved cefazolin in the dosage of 2.0 g,bid,iv for 5～10 d. Results No statistical significant differences of overall clinical effect were observed between two groups .The fully recovery,effective and side reaction rates for the test group were 46.67%,90% and 3.3%,respectively,and for control group the data were 60%,95%,and 0%, respectively.Conclusion Azithromycin injection produced in China is effective and safe in the treatment of respiratory infections.
